Dr. Vredenburgh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
114 Woodland St
Hartford, CT 06105Phone+1 860-714-4680Fax+1 860-714-8047
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1986 - 1990
University of ConnecticutResidency, Internal Medicine, 1983 - 1986
University of Vermont College of MedicineClass of 1983
Certifications & Licensure
CT State Medical License 1985 - 2025
NC State Medical License 1990 - 2013
VT State Medical License 1988 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
- Join now to see all
Clinical Trials
- Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas Start of enrollment: 2005 May 01
- Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma Start of enrollment: 2006 May 01
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 154 citationsMetronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyDavid A. Reardon, Annick Desjardins, James J. Vredenburgh, Sridharan Gururangan, John H. Sampson
British Journal of Cancer. 2009-12-08 - 88 citationsA pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.John H. Sampson, Robert J. Schmittling, Gary E. Archer, Kendra L. Congdon, Smita K. Nair
Plos One. 2012-02-27 - 98 citationsTemozolomide in children with progressive low-grade gliomaSridharan Gururangan, Michael Fisher, Jeffrey C. Allen, James E. Herndon, Jennifer A. Quinn
Neuro-Oncology. 2007-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
